Trinity League India Ltd.
Snapshot View

12.16 ▼0%

04 August 2021, 04:00:00 P.M.

Overview View Details

Sector Miscellaneous Compare with Sector peers
Industry Miscellaneous Compare with Industry peers
Website http://www.trinityasia.in
Financial Indicators
Market Cap 6.16 Cr.
Earnings per share (EPS) -0.97 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2021-03
Industry PE 114.86 Trailing Twelve Months Ending 2021-03
Book Value / Share 5.77 Trailing Twelve Months Ending 2021-03
Price to Book Value 2.11 Calculated using Price: 12.16
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 0.51 Cr. 5,066,900 Shares
FaceValue 10
Company Profile

Trinity League India (formerly known as Dr. Wellman’s Homoeopathic Laboratory Ltd.) was incorporated as a private limited company in 1988 and became a public limited company in Feb 1995. Earlier the company was engaged in the manufacture of homeopathic medicines, health care products and herbal hair care products. Currently, the company is diversifying in other fields for more expansion and growth and engaged in the rendering of financial advisory services, insurance related risk management services and the management consultancy services etc.

Business of the company 

The company is diversifying in other fields for more expansion and growth and engaged in the rendering of financial advisory services, insurance related risk management services and the management consultancy services etc. Earlier the company was engaged in the manufacture of homeopathic medicines, health care products and herbal hair care products.

Main object to be pursued by the company:-

  • To render financial advisory services, investment advisory services, insurance related risk management services and the management consultancy services and to carry out valuation certification of loss assessment for assets of various kinds.    
  • To carry on the business of an investment company and to buy, undertake, lease, invest in, acquire and hold shares, stocks, debentures stock, Bonds, obligations and securities of any kind issued or guaranteed by any company constituted or carrying on Business in India or elsewhere and to promote, establish and undertake financial ventures of all kinds, and to carry out the said activities either on its own or in alliance with any other person/body/bodies corporate incorporated in India or overseas either under the strategic alliance or joint ventures or any other arrangement.  
  • To carry on the business whether in India or abroad of developers, builders, creators, contractors of all and any kinds of infrastructure facilities and services relating to integrated township, railways, airports, roads, power generation, distribution, power trading or any kind of similar activities.  
  • To act as financial consultants, management consultants and to provide advice, services, consultancy in various fields, general administrative, secretarial, commercial, financial legal, economic, labour, industrial, accountancy.   
  • To act as consultants or advisors of any firm, body corporate, association or other undertaking, to act as consultants or advisors and to undertake part in the management supervision or control of the business or operation of any person, firm, body corporate, association or other undertaking and, if necessary, for such purpose or purpose to appoint and remunerate any offices of the company, accountants or other experts or agents.     
  • To carry on the business of financial and investment consultants, finance brokers, stock brokers, underwriters and to carry on the business generally carried on by finance and investment companies.  
  • To lend and advance money and assets of all kinds or give credit on any terms or mode and with or without security to any individual, firm, body corporate or any other entity (including without prejudice to the generality of the foregoing any holding company, subsidiary or fellow subsidiary of company or any other company whether or not associated in any way with the company), to enter into guarantees, contracts of indemnity and surety ships of all kinds.  
  • To carry on the business of manufacturers, chemists, druggists, importers of and dealers in Homoeopathic, herbal and Ayurvedic pharmaceuticals, medical related chemical and other preparation thereof and articles, compounds, drugs, cosmetics, toiletries and dealers in chemical, surgical and scientific apparatus and materials.  
  •  To carry on the business of manufacture, import, export and dealers, in all kinds of Homeopathic medicines, pharmaceutical products, drugs, scents, toilet requisites and cosmetics.
  • To carry on the business as providers of all medical requisites for Government departments and agencies, medical depots, dispensaries, hospitals, patients and invalids.
  • To manufacture, produce, pack repack, import, export, buy, sell and deal in restoratives and / or foods, especially those suitable or deemed to be suitable for infants, invalids and convalescents.  
  • To carry on the business of vialling, bottling, packing, re-packing and processing of capsules, syrups, tablets, injectables, aerosols, ointments and cosmetics prepares and / or invented at its own laboratory or otherwise.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
1 Week
+4.92%
1 Month
+4.65%
3 Month
-3.18%
6 Month
+1.33%
1 Year
-1.54%
2 Year
-12.52%
5 Year
+124.35%
1 years 2020-03
Return on Equity (%) -6.81
Return on Capital Employed (%) -4.23
Return on Assets (%) -5.24

Balance Sheet View Details

Particulars 1 years 2020-03 Rs. Cr.
Shh. Funds 3
Non Curr. Liab. 0
Curr. Liab. 1
Minority Int.
Equity & Liab. 4
Non Curr. Assets 3
Curr. Assets 1
Misc. Exp. not W/O
Total Assets 4

Profit Loss View Details

Particulars 1 years 2020-03 Rs. Cr.
Net Sales 0
Other Income 0
Total Income 0
Total Expenditure -1
PBIDT 0
Interest 0
Depreciation 0
Taxation
Exceptional Items
PAT 0

Cash Flow View Details

Particulars 1 years 2020-03 Rs. Cr.
Cash Fr. Operatn. 0
Cash Fr. Inv. 0
Cash Fr. Finan. 0
Net Change -1
Cash & Cash Eqvt 0

Shareholding Pattern View Details

9 Qtrs 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%)
Promoter 54.69 54.69 54.69 54.69 54.69 54.69 54.69 54.69 54.69
Public 45.31 45.31 45.31 45.31 45.31 45.31 45.31 45.31 45.31
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Thu, 05 Aug 2021
Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On 13Th August 2021
TRINITY LEAGUE INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2021 inter alia to consider and approve In compliance of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we have to intimate you that a meeting of the Board of Directors of the Company will be held on Friday 13th August 2021 at 02:00 PM at Noida Uttar Pradesh interalia to consider and approve the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended 30th June 2021.

Please be also advised that in accordance with Code of Conduct to Regulate Monitor and Report Trading by Designated Persons of the Company pursuant to SEBI (Prohibition of lnsider Trading) Regulations 2015 the Trading Window of the Company is already closed from 01st July 2021 and shall reopen on 16th August 2021.

Submitted for your kind information and necessary records.

Fri, 30 Jul 2021
Change Of Name Of Chief Financial Officer (CFO) Of The Company.
We hereby inform that consequent to change of name in the records of the Chief Financial Officer (CFO) in the relevant documents PAN Aadhaar and Registrar of Companies/ MCA data we inform you that the Name of CFO in Changed from Summiti Sharma to Summiti Jain.
Fri, 30 Jul 2021
Annual Disclosure Under Regulation 30(1) And 30(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011
Dear Sir

As required under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations 2011 the company is in receipt of the Annual disclosure from promoters for the year ended 31st March 2021.

A disclosure received from promoters is enclosed herewith for your reference.

Submitted for your kind information and necessary records.

Technical Scans View Details

Wed, 04 Aug 2021
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Opening at High Opening at High
Opening at Low Opening at Low
Closing Above Previous High Closing Above Previous High
Close Within 52 Week High Zone Close Within 52 Week High Zone

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Syngene International Ltd. 24,775.24 618.15 -0.4%
Quess Corp Ltd. 12,588.67 852.00 -4.2%
RattanIndia Enterprises Ltd. 7,865.11 56.90 -4.9%
Sun Pharma Advanced Research Company Ltd. 7,564.00 288.65 +5.3%
SIS Ltd. 6,938.39 472.75 -2.9%
TeamLease Services Ltd. 6,792.55 3,973.00 +0.3%
Just Dial Ltd. 6,035.66 967.75 +0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Syngene International Ltd. Consolidated 2021-06 58.40 618.15 -0.4%
Quess Corp Ltd. Consolidated 2021-03 217.51 852.00 -4.2%
RattanIndia Enterprises Ltd. Consolidated 2021-03 0.00 56.90 -4.9%
Sun Pharma Advanced Research Company Ltd. Standalone 2021-06 0.00 288.65 +5.3%
SIS Ltd. Consolidated 2021-06 18.78 472.75 -2.9%
TeamLease Services Ltd. Consolidated 2021-06 77.65 3,973.00 +0.3%
Just Dial Ltd. Consolidated 2021-06 47.41 967.75 +0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Syngene International Ltd. Consolidated 2021-06 8.78 618.15 -0.4%
Quess Corp Ltd. Consolidated 2021-03 5.37 852.00 -4.2%
RattanIndia Enterprises Ltd. Consolidated 2021-03 92.70 56.90 -4.9%
Sun Pharma Advanced Research Company Ltd. Standalone 2021-06 -32.72 288.65 +5.3%
SIS Ltd. Consolidated 2021-06 3.89 472.75 -2.9%
TeamLease Services Ltd. Consolidated 2021-06 10.01 3,973.00 +0.3%
Just Dial Ltd. Consolidated 2021-06 4.79 967.75 +0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Syngene International Ltd. Consolidated 2021-03 0.28 618.15 -0.4%
Quess Corp Ltd. Consolidated 2020-03 0.51 852.00 -4.2%
RattanIndia Enterprises Ltd. Consolidated 2020-03 0.00 56.90 -4.9%
Sun Pharma Advanced Research Company Ltd. Standalone 2020-03 -3.67 288.65 +5.3%
SIS Ltd. Consolidated 2021-03 0.74 472.75 -2.9%
TeamLease Services Ltd. Consolidated 2020-03 0.14 3,973.00 +0.3%
Just Dial Ltd. Consolidated 2020-03 0.00 967.75 +0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Syngene International Ltd. Consolidated 2021-03 16.59 618.15 -0.4%
Quess Corp Ltd. Consolidated 2020-03 -16.80 852.00 -4.2%
RattanIndia Enterprises Ltd. Consolidated 2020-03 -0.24 56.90 -4.9%
Sun Pharma Advanced Research Company Ltd. Standalone 2020-03 -225.08 288.65 +5.3%
SIS Ltd. Consolidated 2021-03 23.02 472.75 -2.9%
TeamLease Services Ltd. Consolidated 2020-03 6.75 3,973.00 +0.3%
Just Dial Ltd. Consolidated 2020-03 24.85 967.75 +0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Syngene International Ltd. Consolidated 2021-03 15.40 618.15 -0.4%
Quess Corp Ltd. Consolidated 2020-03 -5.79 852.00 -4.2%
RattanIndia Enterprises Ltd. Consolidated 2020-03 0.63 56.90 -4.9%
Sun Pharma Advanced Research Company Ltd. Standalone 2020-03 -178.22 288.65 +5.3%
SIS Ltd. Consolidated 2021-03 21.05 472.75 -2.9%
TeamLease Services Ltd. Consolidated 2020-03 16.25 3,973.00 +0.3%
Just Dial Ltd. Consolidated 2020-03 31.48 967.75 +0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Syngene International Ltd. Consolidated 2021-03 2,184.30 618.15 -0.4%
Quess Corp Ltd. Consolidated 2020-03 10,991.48 852.00 -4.2%
RattanIndia Enterprises Ltd. Consolidated 2020-03 56.90 -4.9%
Sun Pharma Advanced Research Company Ltd. Standalone 2020-03 76.81 288.65 +5.3%
SIS Ltd. Consolidated 2021-03 9,127.30 472.75 -2.9%
TeamLease Services Ltd. Consolidated 2020-03 5,200.72 3,973.00 +0.3%
Just Dial Ltd. Consolidated 2020-03 953.11 967.75 +0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Syngene International Ltd. Consolidated 2021-03 404.90 618.15 -0.4%
Quess Corp Ltd. Consolidated 2020-03 -418.05 852.00 -4.2%
RattanIndia Enterprises Ltd. Consolidated 2020-03 -0.38 56.90 -4.9%
Sun Pharma Advanced Research Company Ltd. Standalone 2020-03 -312.40 288.65 +5.3%
SIS Ltd. Consolidated 2021-03 366.66 472.75 -2.9%
TeamLease Services Ltd. Consolidated 2020-03 37.06 3,973.00 +0.3%
Just Dial Ltd. Consolidated 2020-03 272.31 967.75 +0.1%